| Literature DB >> 17169765 |
S Maciá Escalante1, A Rodríguez Lescure, J M Segura Ibáñez, J Sáez Castán, C Guillén Ponce, A Carrato Mena.
Abstract
The main treatment of asctrocytomas is surgery, which serves a double purpose: diagnosis and treatment. Surgery can be complemented with radiotherapy. With respect to chemotherapy, there continues to be a controversy as to whether it has the capacity to overcome the blood-brain barrier. An interesting option has been the implantation of biodegradable polymers of carmustine that are placed in the cavity left by the surgical procedure. With respect to the cerebral edema that can be associated with the carmustine implants, there can appear images in follow-up that are suggestive of relapse.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17169765 DOI: 10.1007/s12094-006-0155-0
Source DB: PubMed Journal: Clin Transl Oncol ISSN: 1699-048X Impact factor: 3.405